- The U.S. Food and Drug Administration has declined to reduce the severity of its warning about neuropsychiatric side effects associated with Pfizer Inc's quit-smoking drug Chantix, the agency said on Monday.
Friday, 22 November 2024
News
News Sources
Life Style
News Letter
Subscribe our Email News Letter to get Instant Update at anytime
About Oases News
OASES News is a News Agency with the central idea of diseminating credible, evidence-based, impeccable news and activities without stripping all technicalities involved in news reporting.
